COPS5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.853800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.246000E-01
Normal-vs-Stage2
6.972600E-01
Normal-vs-Stage3
8.656000E-01
Normal-vs-Stage4
8.889400E-01
Stage1-vs-Stage2
6.743600E-01
Stage1-vs-Stage3
8.972800E-01
Stage1-vs-Stage4
9.414200E-01
Stage2-vs-Stage3
8.668400E-01
Stage2-vs-Stage4
7.999200E-01
Stage3-vs-Stage4
9.605600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.661800E-01
Normal-vs-AfricanAmerican
8.236600E-01
Normal-vs-Asian
8.587400E-01
Caucasian-vs-AfricanAmerican
7.533400E-01
Caucasian-vs-Asian
9.271600E-01
AfricanAmerican-vs-Asian
9.229400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.895000E-01
Normal-vs-Female
6.818400E-01
Male-vs-Female
9.948800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.760800E-01
Normal-vs-Age(41-60Yrs)
5.345800E-01
Normal-vs-Age(61-80Yrs)
7.601400E-01
Normal-vs-Age(81-100Yrs)
3.231200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.864250E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.643400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.005650E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.332600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.335000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.213800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.682600E-01
Normal-vs-Daily Drinker
6.887800E-01
Normal-vs-Weekly Drinker
7.739600E-01
Normal-vs-Occasional Drinker
2.381200E-01
Normal-vs-Social Drinker
6.387200E-01
Non Drinker-vs-Daily Drinker
6.156800E-01
Non Drinker-vs-Weekly Drinker
3.018600E-01
Non Drinker-vs-Occasional Drinker
1.036620E-01
Non Drinker-vs-Social Drinker
8.683800E-01
Daily Drinker-vs-Weekly Drinker
2.040200E-01
Daily Drinker-vs-Occasional Drinker
4.211800E-01
Daily Drinker-vs-Social Drinker
7.387600E-01
Weekly Drinker-vs-Occasional Drinker
1.538140E-02
Weekly Drinker-vs-Social Drinker
2.261600E-01
Occasional Drinker-vs-Social Drinker
1.561390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.796000E-01
Normal-vs-Grade 2
5.869800E-01
Normal-vs-Grade 3
5.492000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.167200E-01
Grade 1-vs-Grade 3
1.296030E-01
Grade 1-vs-Grade 4
3.796000E-01
Grade 2-vs-Grade 3
3.396400E-01
Grade 2-vs-Grade 4
5.869800E-01
Grade 3-vs-Grade 4
5.492000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.177000E-01
Normal-vs-NonDiabetic
6.589600E-01
Diabetic-vs-NonDiabetic
5.531000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.441000E-01
Normal-vs-NoPancreatitis
6.938200E-01
Pancreatitis-vs-NoPancreatitis
5.554000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.910000E-01
Normal-vs-N1
6.634200E-01
N0-vs-N1
9.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.460790E-01
Normal-vs-TP53-NonMutant
9.932000E-01
TP53-Mutant-vs-TP53-NonMutant
3.38109999997727E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
